Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 952

1.

Expression profile of nine novel genes differentially expressed in hepatitis B virus-associated hepatocellular carcinomas.

Kim MY, Park E, Park JH, Park DH, Moon WS, Cho BH, Shin HS, Kim DG.

Oncogene. 2001 Jul 27;20(33):4568-75.

3.

[Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].

Tu H, Gao HF, Ma GH, Liu Y.

Zhonghua Yi Xue Za Zhi. 2006 May 16;86(18):1249-52. Chinese.

PMID:
16796883
4.

Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.

Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.

Int J Oncol. 2006 Aug;29(2):315-27.

PMID:
16820872
5.
6.

Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.

Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.

Int J Oncol. 2006 Feb;28(2):383-91.

PMID:
16391793
7.

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms.

Bréchot C.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S56-61. Review.

PMID:
15508104
8.

Reduction of double-stranded RNA-activated protein kinase in hepatocellular carcinoma associated with hepatitis B virus.

Chen GG, Lai PB, Ho RL, Chan PK, Xu H, Wong J, Lau WY.

J Med Virol. 2004 Jun;73(2):187-94.

PMID:
15122791
9.

Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.

Li N, Long Y, Fan X, Liu H, Li C, Chen L, Wang Z.

J Exp Clin Cancer Res. 2009 Aug 28;28:122. doi: 10.1186/1756-9966-28-122.

10.
11.

Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma.

Huang HP, Tsuei DJ, Wang KJ, Chen YL, Ni YH, Jeng YM, Chen HL, Hsu HY, Chang MH.

J Gastroenterol Hepatol. 2005 Aug;20(8):1206-14.

PMID:
16048568
12.

Detection of hepatitis B virus x transcripts in human hepatocellular carcinoma tissues.

Kobayashi S, Saigoh Ki, Urashima T, Asano T, Isono K.

J Surg Res. 1997 Dec;73(2):97-100.

PMID:
9441800
13.

Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues.

Urashima T, Saigo K, Kobayashi S, Imaseki H, Matsubara H, Koide Y, Asano T, Kondo Y, Koike K, Isono K.

J Hepatol. 1997 Apr;26(4):771-8.

PMID:
9126788
14.
15.

Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA.

Tamori A, Yamanishi Y, Kawashima S, Kanehisa M, Enomoto M, Tanaka H, Kubo S, Shiomi S, Nishiguchi S.

Clin Cancer Res. 2005 Aug 15;11(16):5821-6.

16.

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.

Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC.

Carcinogenesis. 1993 May;14(5):987-92.

PMID:
8389256
18.

Molecular mechanism of hepatocarcinogenesis.

Sheu JC.

J Gastroenterol Hepatol. 1997 Oct;12(9-10):S309-13. Review.

PMID:
9407351
20.

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A, Farinati F, Missale G, Smedile A, Tiribelli C, Villa E, Raimondo G.

Gastroenterology. 2004 Jan;126(1):102-10.

PMID:
14699492
Items per page

Supplemental Content

Write to the Help Desk